Magna International: BMO Lowers Estimates On Lower Production Expectations

On August 16 BMO Capital Markets slightly lowered their 12-month price target on Magna International (TSX: MG) while reiterating their outperform rating. They say the reason for the price target change is due to revising their third quarter earnings per share estimate to $1.47 from $1.63.

Magna International has 10 analysts covering the stock, with 1 having a strong buy rating, 8 have buy ratings and 1 analyst has a hold rating. The consensus 12-month price target sits at $111 while the street high comes in at $129.45 and the lowest is $88.

With the chip shortage still heavily in effect, BMO has lowered its expectations around production. They say that the West Detroit Three production is now expected to increase 31% sequentially, lower than their original 50% estimate. The companies revenue meanwhile is expected to grow 14%, underperforming its production increase.

The company’s western production is expected to decrease 4.5% sequentially, which is 1% weaker than their original estimate. Revenues from Magna’s European platforms are estimated to decrease 5.5% sequentially. This is primarily due to the companies top platforms, the BMW 1-Series and Volkswagen Tiguan, both expected to drop 22% sequentially.

Below you can see BMO’s updated third quarter, full year 2021, and 2022 estimates.


Information for this briefing was found via Sedar and Refinitiv. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Silver’s Finally Breaking the System | Keith Neumeyer – First Majestic

The Best News for Gold Was the Drop! – Peter Grandich

McEwen Copper: The Los Azules Feasibility Study

Recommended

Altamira Gold Identifies Presence Of Second Mineralized Porphyry Body At Cajueiro

Steadright To Conduct Multi-Phased Exploration At Historic Goundafa Polymetallic Mine

Related News

Antibe Therapeutics: Canaccord Initiates Coverage, Issues $1.50 Price Target

Recently, Canaccord Genuity’s Tania Gonsalves initiated coverage on Antibe Therapeutics (TSXV: ATE), a biotechnology company...

Tuesday, August 18, 2020, 01:46:28 PM

Meta Platforms: Canaccord Anticipates Headwinds To Persist, Cuts Target To $200

On October 26th, Meta Platforms Inc (Nasdaq: META) reported its third-quarter financial results. The company...

Thursday, November 3, 2022, 12:52:00 PM

Canaccord Drops Antibe’s Price Target To $0.70 Following Asset Sale

Antibe Therapeutics Inc. (TSX: ATE) recently reported their full-year 2022 results, wherein the company reported...

Friday, July 15, 2022, 02:25:00 PM

Kinross: BMO Lifts Target To $7.50 After Project Updates

On June 28, Kinross Gold Corporation’s (TSX: K) management provided an updated presentation on their...

Sunday, July 3, 2022, 05:11:00 PM

Nuvei: Canaccord Lifts Price Target To US$140

On September 23, Nuvei Corporation (TSX: NVEI) announced that they have partnered with U.S internet...

Thursday, September 30, 2021, 03:49:00 PM